pneumococcal conjugate vaccine
Sinusitis and Pneumonia Hospitalization After Introduction of Pneumococcal Conjugate Vaccine
... Although pneumococcal conjugate vaccine (PCV) is effective against invasive pneumococcal disease, its effectiveness against pneumonia is less consistent, and its effect on sinusitis is not ...
11
Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster
... There are a number of studies evaluating the duration of the effect of a 3-PCV-dose schedule on VT carriage. In one study, the effects on VT colonization were no longer evident by the ages of 2 to 5 years following 3 PCV ...
7
Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine
... a pneumococcal conjugate vaccine had previously also been shown for infants and patients with Hodgkin ⬘ s disease after treatment (9, ...or conjugate vaccine ...
7
Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults
... 13-valent pneumococcal conjugate vaccine (PCV13) coadministered with trivalent inactivated influenza vaccine (TIV) in pneumococcal vaccine-naive ...for pneumococcal ...
8
Safety of a 13 Valent Pneumococcal Conjugate Vaccine in Elderly Adults Previously Immunized with a 23 Valent Pneumococcal Polysaccharide Vaccine: An Open Label Trial
... 13-valent pneumococcal conjugate vaccine (PCV13) in 1049 individuals aged ≥68 years, who had previously been immunized with the unconjugated 23-valent pneumococcal polysaccharide ...
7
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
... mate vaccine parameters, mixing patterns and to infer the degree of competition between VT and ...coccal conjugate vaccine and to estimate effects of alter- native vaccine ...of vaccine ...
15
13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Preterm Versus Term Infants
... infants. This study evaluated preterm infants with a GA of , 29 weeks, an underrepresented population in previous pneumococcal conjugate vaccine studies. One possible limitation of this study was the ...
13
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers
... 13-valent pneumococcal conjugate vaccine (PCV13) has been developed to improve protection against pneumococcal disease beyond that possible with the licensed 7-valent vaccine ...
10
Estimating the Vaccine Effectiveness Against Serotype 3 for the 13-Valent Pneumococcal Conjugate Vaccine: A Dynamic Modeling Approach
... 13-valent pneumococcal conjugate vaccine (PCV13) is the only PCV licensed to protect against serotype 3 in ...protection vaccine effectiveness (VE) for serotype ...invasive pneumococcal ...
11
Imputing direct and indirect vaccine effectiveness of childhood pneumococcal conjugate vaccine against invasive disease by surveying temporal changes in nasopharyngeal pneumococcal colonization
... of pneumococcal conjugate vaccine (PCV) against invasive pneumococcal disease (IPD), calls for alternate strategies to assess ...in vaccine-serotype colonization and IPD due to ...
25
Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease
... POTENTIAL CONFLICT OF INTEREST: National Institute for Health and Welfare has received research funding from GlaxoSmithKline Vaccines for the conduct of a nationwide effectiveness trial of the 10-valent ...
8
Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children
... from pneumococcal conjugate vaccine (PCV)-unvaccinated and 7-valent PCV (PCV7)-vaccinated cohorts of HIV-uninfected children from Soweto, South Africa, were retrospectively ...separate ...
12
Pediatricians' Adherence to Pneumococcal Conjugate Vaccine Shortage Recommendations in 2 National Shortages
... heptavalent pneumococcal conjugate vaccine shortages (first short- age: 86%; second shortage: ...heptavalent pneumococcal conjugate vaccine dose for healthy children was ...
11
Pneumococcal conjugate vaccine implementation in middle-income countries
... Accelerated vaccine introduction; CDC: Center for Disease Prevention and Control; DTP3: Diphtheria-tetanus- pertussis; GAPPD: Integrated Global Action Plan for the Prevention and Control of Pneumonia and ...
15
Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine
... of pneumococcal conjugate vaccine on hospitalization ...invasive pneumococcal disease (pneumonia, sepsis, or meningitis caused by Streptococcus pneumoniae) decreased 50%, to ...
10
Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate Vaccine
... by pneumococcal conjugate vaccine (sim- ple otitis media, complex otitis media, moderate pneu- monia, severe pneumonia, bacteremia, and meningitis) and 1 vaccine-related adverse event (fever ...
10
Cost effectiveness analysis of pneumococcal conjugate vaccine 13 valent in older adults in Colombia
... a pneumococcal vaccine with a different tech- nology was launched, which conjugates pneumococcal serotypes with a diphtheria protein ...the pneumococcal conjugate vaccine ...
9
Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
... 7-valent pneumococcal conjugate vaccine (PCV7), available since 2000, has resulted in a dramatic reduction in the inci- dence of invasive pneumococcal disease (IPD) attributable to serotypes ...
7
Immune Response in Infants to the Heptavalent Pneumococcal Conjugate Vaccine against Vaccine-Related Serotypes 6A and 19A
... 7-valent pneumococcal conjugate vaccine (PCV7) elicits good immune response to and is effective against vaccine ...against vaccine-related serotypes is ...(seven vaccine ...
6
Pneumococcal carriage among children under five in Accra, Ghana, five years after the introduction of pneumococcal conjugate vaccine
... of pneumococcal se- rotypes circulating in Ghana [13 – ...PCV-13 vaccine coverage was estimated to be approximately ...of vaccine serotypes but there has been an increase in non-PCV serotypes [2, ...
11